VIVANZAPharmaceuticals
Vivanza Biosciences Ltd — Cash Flow Statement
₹1.76
+0.00%
Vivanza Biosciences Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Free Cash Flow | -2.51 Cr | 2.01 Cr | -0.95 Cr | 2.47 Cr | — |
| Capital Expenditure | -79000.00 | -0.04 Cr | — | — | -0.02 Cr |
| End Cash Position | 0.12 Cr | 0.17 Cr | 0.14 Cr | 0.06 Cr | — |
| Beginning Cash Position | 0.17 Cr | 0.14 Cr | 0.06 Cr | 0.07 Cr | — |
| Changes In Cash | -0.05 Cr | 0.03 Cr | 0.09 Cr | -0.01 Cr | — |
| Financing Cash Flow | 2.46 Cr | -1.98 Cr | 1.03 Cr | -2.48 Cr | — |
| Net Other Financing Charges | -1000.00 | — | 1000.00 | -0.59 Cr | -0.20 Cr |
| Interest Paid Cff | -0.35 Cr | -0.41 Cr | -0.42 Cr | -0.41 Cr | — |
| Net Issuance Payments Of Debt | 2.81 Cr | -1.57 Cr | 1.45 Cr | -1.48 Cr | — |
| Net Short Term Debt Issuance | -0.02 Cr | 2.51 Cr | -2.20 Cr | -0.87 Cr | — |
| Net Long Term Debt Issuance | 2.83 Cr | -4.08 Cr | 3.65 Cr | -0.60 Cr | — |
| Investing Cash Flow | -79000.00 | -0.04 Cr | 0.00 | 0.00 | — |
| Dividends Received Cfi | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Investment Purchase And Sale | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Sale Of Investment | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Purchase Of Investment | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net PPE Purchase And Sale | -79000.00 | -0.04 Cr | 0.00 | 0.00 | — |
| Sale Of PPE | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Purchase Of PPE | -79000.00 | -0.04 Cr | 0.00 | 0.00 | — |
| Operating Cash Flow | -2.50 Cr | 2.04 Cr | -0.95 Cr | 2.47 Cr | — |
| Taxes Refund Paid | -70000.00 | -0.15 Cr | -0.12 Cr | 11000.00 | — |
| Change In Working Capital | -2.19 Cr | 1.07 Cr | -1.97 Cr | 1.72 Cr | — |
| Change In Other Current Liabilities | 0.64 Cr | 1.74 Cr | -1.52 Cr | 2.64 Cr | — |
| Change In Other Current Assets | 0.10 Cr | -0.08 Cr | -0.13 Cr | -0.05 Cr | — |
| Change In Payable | -5.62 Cr | -1.31 Cr | 4.06 Cr | 1.62 Cr | — |
| Change In Inventory | -0.26 Cr | 0.47 Cr | -0.05 Cr | -1.77 Cr | — |
| Change In Receivables | 3.16 Cr | 0.13 Cr | -4.45 Cr | -0.68 Cr | — |
| Other Non Cash Items | 0.35 Cr | 0.41 Cr | 0.42 Cr | 0.41 Cr | — |
| Depreciation And Amortization | 0.01 Cr | 0.01 Cr | 26000.00 | 74000.00 | — |
| Depreciation | 0.01 Cr | 0.01 Cr | 26000.00 | 74000.00 | — |
| Net Income From Continuing Operations | -0.67 Cr | 0.70 Cr | 0.72 Cr | 0.33 Cr | — |
| Other Cash Adjustment Outside Changein Cash | — | 1000.00 | — | — | 1.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Vivanza Biosciences Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.